(manufacturer narrative = t, corrected data = f) (b)(4).Product not yet returned for evaluation.Most likely underlying root cause: mlc-140- supplier manufacturing defect.Based on the post market review syr-pmr-100 and review of the fda's total product life cycle (tplc) - total device problems, for possible delay in administration of insulin.Reference - capa (b)(4).Note: manufacturer contacted customer in a follow-up call to ensure that the initial concern was resolved - unable to establish contact with the customer at this time.Product notification letter sent to customer to contact customer care.
|